Keyphrases
Interobserver Agreement
100%
Prostate Cancer
100%
Positron Emission Tomography-computed Tomography (PET-CT)
100%
Bone Metastasis
100%
18F-NaF
100%
Observer Accuracy
100%
Sodium Fluoride PET
100%
18F-NaF PET-CT
66%
Patient-level
44%
Patients with Prostate Cancer
33%
PET Scan
33%
Diagnostic Performance
22%
Three-class Classification
22%
Lesion number
22%
Lesion Level
22%
Dichotomous Scale
22%
Sensitivity Analysis
11%
Positive Predictive Value
11%
Final Diagnosis
11%
Armamentarium
11%
Unweighting
11%
Negative Predictive Value
11%
Primary Staging
11%
Biochemical Recurrence
11%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
11%
Linear Weights
11%
Category Scale
11%
Equivocal Lesions
11%
Medicine and Dentistry
Prostate Cancer
100%
Bone Metastasis
100%
Positron Emission Tomography-Computed Tomography
100%
Sodium Fluoride F 18
100%
Fluorine-18
77%
Diagnostic Performance
22%
Diagnosis
11%
Final Diagnosis
11%
Biochemical Recurrence
11%
Sodium Fluoride
11%
Castration Resistant Prostate Cancer
11%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Bone Metastasis
100%
Sodium Fluoride F 18
100%
Fluorine 18
77%
Sodium Fluoride
11%
Biochemical Recurrence
11%
Castration Resistant Prostate Cancer
11%
Neuroscience
Positron Emission Tomography-Computed Tomography
100%
Fluorine-18
87%
Biochemistry, Genetics and Molecular Biology
Positron Emission Tomography-Computed Tomography
100%
X-Ray Computed Tomography
37%
Immunology and Microbiology
Positron Emission Tomography-Computed Tomography
100%
X-Ray Computed Tomography
37%